Engineering an Implantable Bioartificial Pancreas to Balance Transport, Containment, and Retrieval.

Abstract

Background: An implantable bioartificial pancreas must accommodate a therapeutically meaningful cell dose while simultaneously maintaining oxygen and nutrient transport, glucose-responsive insulin secretion, immune protection, cellular containment, mechanical integrity, and surgical retrievability. Although promising results have been obtained in preclinical models, these advances have not consistently translated into clinically meaningful endocrine function.

Methods: This narrative review integrates experimental, computational, preclinical, and clinical evidence relevant to implantable bioartificial pancreas design. Particular attention is given to the coupled effects of cell size and loading density, membrane and device geometry, oxygen supply, vascular proximity, extracellular matrix, foreign-body response, mechanical integrity, containment, and retrieval. Published quantitative examples are distinguished from model assumptions, illustrative calculations, and proposed engineering criteria.

Results: Available evidence indicates that device performance is governed by interacting rather than independent constraints. Increasing cell loading can compromise oxygenation, whereas reducing diffusion distance may increase device footprint or complicate retrieval. Cell-excluding membranes do not necessarily prevent soluble inflammatory injury, and improved oxygenation can introduce additional maintenance requirements and failure modes. Clinical experience further shows that cell survival alone does not ensure therapeutically meaningful insulin secretion. Accordingly, dynamic transport testing, containment assessment, hydrated mechanical testing, host-response evaluation, and planned retrieval should be evaluated within the same device configuration.

Conclusions: Progress toward a clinically useful bioartificial pancreas requires reproducible endocrine function at a surgically manageable scale, explicit evaluation of soluble immune injury and oxygen-support failure, and documented complete retrieval. Configuration-matched testing and predefined engineering benchmarks may improve interpretation of both successful and unsuccessful implant studies.